Search research articles
Contact Us
Filters
Showing results (91-100 of 100) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 100 results.
Blood
|
February 22, 2013
Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant
Jenny McIntosh, Peter J Lenting, Cecilia Rosales, et al.
Nature Communications
|
December 22, 2019
Forty-five patient-derived xenografts capture the clinical and biological heterogeneity of Wilms tumor
Andrew J Murphy, Xiang Chen, Emilia M Pinto, et al.
The New England Journal of Medicine
|
June 11, 2025
Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia B
Ulrike M Reiss, Andrew M Davidoff, Edward G D Tuddenham, et al.
The New England Journal of Medicine
|
November 20, 2014
Long-term safety and efficacy of factor IX gene therapy in hemophilia B
Amit C Nathwani, Ulreke M Reiss, Edward G D Tuddenham, et al.
The New England Journal of Medicine
|
December 14, 2011
Adenovirus-associated virus vector-mediated gene transfer in hemophilia B
Amit C Nathwani, Edward G D Tuddenham, Savita Rangarajan, et al.
Research Square
|
March 30, 2023
The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition: A Report from the Children's Oncology Group AREN18B5-Q Study
Andrew J Murphy, Changde Cheng, Justin Williams, et al.
Nature Communications
|
December 18, 2023
Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children's Oncology Group AREN18B5-Q
Andrew J Murphy, Changde Cheng, Justin Williams, et al.
Nature Communications
|
September 17, 2025
RBM39 degrader invigorates innate immunity to eradicate neuroblastoma despite cancer cell plasticity
Shivendra Singh, Jie Fang, Hongjian Jin, et al.
Communications Biology
|
April 8, 2024
Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin
Karuna Mittal, Garrett W Cooper, Benjamin P Lee, et al.
Cell Reports
|
March 18, 2026
Developmental reprogramming underlies chemotherapy resistance in favorable-histology Wilms tumor
Andrew M Fleming, Carolyn M Jablonowski, Hongjian Jin, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 100) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 100 results.
Blood
|
February 22, 2013
Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant
Jenny McIntosh, Peter J Lenting, Cecilia Rosales, et al.
Nature Communications
|
December 22, 2019
Forty-five patient-derived xenografts capture the clinical and biological heterogeneity of Wilms tumor
Andrew J Murphy, Xiang Chen, Emilia M Pinto, et al.
The New England Journal of Medicine
|
June 11, 2025
Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia B
Ulrike M Reiss, Andrew M Davidoff, Edward G D Tuddenham, et al.
The New England Journal of Medicine
|
November 20, 2014
Long-term safety and efficacy of factor IX gene therapy in hemophilia B
Amit C Nathwani, Ulreke M Reiss, Edward G D Tuddenham, et al.
The New England Journal of Medicine
|
December 14, 2011
Adenovirus-associated virus vector-mediated gene transfer in hemophilia B
Amit C Nathwani, Edward G D Tuddenham, Savita Rangarajan, et al.
Research Square
|
March 30, 2023
The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition: A Report from the Children's Oncology Group AREN18B5-Q Study
Andrew J Murphy, Changde Cheng, Justin Williams, et al.
Nature Communications
|
December 18, 2023
Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children's Oncology Group AREN18B5-Q
Andrew J Murphy, Changde Cheng, Justin Williams, et al.
Nature Communications
|
September 17, 2025
RBM39 degrader invigorates innate immunity to eradicate neuroblastoma despite cancer cell plasticity
Shivendra Singh, Jie Fang, Hongjian Jin, et al.
Communications Biology
|
April 8, 2024
Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin
Karuna Mittal, Garrett W Cooper, Benjamin P Lee, et al.
Cell Reports
|
March 18, 2026
Developmental reprogramming underlies chemotherapy resistance in favorable-histology Wilms tumor
Andrew M Fleming, Carolyn M Jablonowski, Hongjian Jin, et al.
Page
of 10